We identified eight common signature genes (CEBPA, TGFBR2, EZH2, JUNB, JUN, FOS, PLAU, COL1A1) and their co-regulated pathways between NSCLC and AMI. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.